These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38171938)

  • 1. Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?
    Bergsagel PL
    Hematol Oncol Clin North Am; 2024 Apr; 38(2):xiii-xv. PubMed ID: 38171938
    [No Abstract]   [Full Text] [Related]  

  • 2. Roadmap to cure multiple myeloma.
    Rodriguez-Otero P; Paiva B; San-Miguel JF
    Cancer Treat Rev; 2021 Nov; 100():102284. PubMed ID: 34597912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management and emerging treatment strategies for multiple myeloma.
    Lei M; Kim EB; Branagan A; Lou U; Zemel M; Raje N
    Rinsho Ketsueki; 2019; 60(9):1243-1256. PubMed ID: 31597850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latest treatment strategies aiming for a cure in transplant-eligible multiple myeloma patients: how I cure younger MM patients with lower cost.
    Suzuki K
    Int J Hematol; 2020 Apr; 111(4):512-518. PubMed ID: 32125606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and treatment of multiple myeloma.
    Mandelli F; Avvisati G; Tribalto M
    Curr Opin Oncol; 1992 Feb; 4(1):73-86. PubMed ID: 1591296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of multiple myeloma in Hungary in 2016].
    Varga G; Mikala G; Váróczy L; Illés Á
    Orv Hetil; 2016 Jan; 157(4):123-37. PubMed ID: 26772825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it possible to cure myeloma without allogeneic transplantation?
    Katodritou E; Papadaki S; Konstantinidou P; Terpos E
    Transfus Apher Sci; 2016 Feb; 54(1):63-70. PubMed ID: 26850930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in haematopoietic stem cell transplantation for multiple myeloma.
    Gahrton G; Björkstrand B
    J Intern Med; 2000 Sep; 248(3):185-201. PubMed ID: 10971785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Therapy for Relapsed/Refractory Multiple Myeloma.
    Castillo JJ
    J Natl Compr Canc Netw; 2019 Nov; 17(11.5):1433-1436. PubMed ID: 31766022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma: advances reported in 2013 are useful in the clinic.
    Anderson K
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):808-11. PubMed ID: 24853222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Treatment Options for the Management of Multiple Myeloma.
    Kumar SK
    J Natl Compr Canc Netw; 2017 May; 15(5S):709-712. PubMed ID: 28515251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?
    Kaloyannidis P; Apostolidis J
    Curr Treat Options Oncol; 2021 Jun; 22(8):65. PubMed ID: 34110512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controversies and progress in the treatment of multiple myeloma].
    Robak T
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):407-11. PubMed ID: 2267190
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of myeloma: cure vs control.
    Rajkumar SV
    Mayo Clin Proc; 2008 Oct; 83(10):1142-5. PubMed ID: 18828974
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies.
    Landgren O
    Hematology Am Soc Hematol Educ Program; 2013; 2013():478-87. PubMed ID: 24319222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes in multiple myeloma.
    Lee SJ
    J Natl Compr Canc Netw; 2004 Jul; 2(4):379-83. PubMed ID: 19795600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeking Convergence and Cure with New Myeloma Therapies.
    Choudhry P; Galligan D; Wiita AP
    Trends Cancer; 2018 Aug; 4(8):567-582. PubMed ID: 30064664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of multiple myeloma.
    Rajkumar SV
    Nat Rev Clin Oncol; 2011 Apr; 8(8):479-91. PubMed ID: 21522124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond.
    Su CT; Ye JC
    J Hematol Oncol; 2021 Jul; 14(1):115. PubMed ID: 34301270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR T cell therapy for multiple myeloma: where are we now and where are we headed?
    Ghosh A; Mailankody S; Giralt SA; Landgren CO; Smith EL; Brentjens RJ
    Leuk Lymphoma; 2018 Sep; 59(9):2056-2067. PubMed ID: 29105517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.